Loading...
Ultragenyx Pharmaceutical Inc.
RARE•NASDAQ
HealthcareBiotechnology
$35.44
$-1.91(-5.11%)
Ultragenyx Pharmaceutical Inc. (RARE) AI-Powered Stock Analysis
See how Ultragenyx Pharmaceutical Inc. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerUltragenyx Pharmaceutical Inc. (RARE) Stock Overall Grade
Ultragenyx Pharmaceutical Inc.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
B+
Good
Grade Breakdown by Metric
See how each financial and market factor contributes to Ultragenyx Pharmaceutical Inc.'s overall stock rating.
Forecast
B+Score
74/100Financial Growth
AScore
80/100Fundamental Growth
C+Score
57/100Key Ratios
C+Score
55/100Sector Comparison
B+Score
75/100Industry Comparison
B+Score
75/100S&P 500 Benchmark
AScore
85/100Analyst Consensus
B+Score
75/100Component Analysis Explained
Understand the key factors behind each Ultragenyx Pharmaceutical Inc. stock grade, including financials, comparisons, and forecasts.